| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | PODD | Common Stock | Gift | $0 | -19.9K | -59.39% | $0.00 | 13.6K | Mar 17, 2022 | Direct | F1 |
| transaction | PODD | Common Stock | Gift | $0 | +19.9K | +310.94% | $0.00 | 26.3K | Mar 17, 2022 | By SP Trust | F1 |
| transaction | PODD | Common Stock | Options Exercise | $439K | +15K | +110.24% | $29.26* | 28.6K | Apr 4, 2022 | Direct | F2 |
| transaction | PODD | Common Stock | Sale | -$4.1M | -15K | -52.43% | $273.25 | 13.6K | Apr 4, 2022 | Direct | F2, F3 |
| holding | PODD | Common Stock | 61.3K | Mar 17, 2022 | By NG Trust |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | PODD | Employee Stock Option (Right to Buy) | Options Exercise | $0 | -15K | -67.97% | $0.00 | 7.07K | Apr 4, 2022 | Common Stock | 15K | $29.26 | Direct | F4 |
| Id | Content |
|---|---|
| F1 | On March 17, 2022, the reporting person transferred 19,903 shares of Insulet common stock to a family trust of which the reporting person is a trustee. The reporting person and members of her immediate family are beneficiaries of the trust. |
| F2 | The transactions reported in this Form 4 were effected pursuant to an existing Rule 10b5-1 trading plan. |
| F3 | The price reported represents the weighted average sale price of the shares sold. The shares were sold at varying prices in the range of $270.79 to $279.59. Specifically: 4,146 shares were sold in the range of $270.79 to $271.77 per share, with a weighted average share price of $271.35; 1,928 shares were sold in the range of $271.79 to $272.73 per share, with a weighted average share price of $272.10; 3,111 shares were sold in the range of $272.80 to $273.77 per share, with a weighted average share price of $273.30; 3,618 shares were sold in the range of $273.78 to $274.77 per share, with a weighted average share price of $274.21; 1,413 shares were sold in the range of $274.78 to $275.35 per share, with a weighted average share price of $275.08; 200 shares were sold in the range of $276.09 to $276.37 per share, with a weighted average share price of $276.23; 142 shares were sold in the range of $277.64 to $278.39 per share, with a weighted average share price of $278.20 and 442 shares were sold in the range of $278.66 to $279.59 per share, with a weighted average share price of $279.28. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. |
| F4 | This option is subject to a four-year vesting period with 25% of the total award vesting one year after the grant date and the remainder vesting in equal quarterly installments each quarter thereafter for 12 quarters, subject to continued employment. |